Responses
Chronic obstructive pulmonary disease
Original article
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.